BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Rose AJ, Park A, Gillespie C, Van Deusen Lukas C, Ozonoff A, Petrakis BA, Reisman JI, Borzecki AM, Benedict AJ, Lukesh WN, Schmoke TJ, Jones EA, Morreale AP, Ourth HL, Schlosser JE, Mayo-Smith MF, Allen AL, Witt DM, Helfrich CD, McCullough MB. Results of a Regional Effort to Improve Warfarin Management. Ann Pharmacother 2017;51:373-9. [PMID: 28367699 DOI: 10.1177/1060028016681030] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
Number Citing Articles
1 Rose AJ, McCullough MB, Jasuja GK. A three-step health services research approach to improve prescribing. Healthc (Amst) 2018;6:135-8. [PMID: 29126852 DOI: 10.1016/j.hjdsi.2017.10.002] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
2 Strong AT, Sharma G, Nor Hanipah Z, Tu C, Brethauer SA, Schauer PR, Cetin D, Aminian A. Adjustments to warfarin dosing after gastric bypass and sleeve gastrectomy. Surgery for Obesity and Related Diseases 2018;14:700-6. [DOI: 10.1016/j.soard.2017.12.021] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 2.5] [Reference Citation Analysis]
3 Rose AJ, Vaiana M. Evidence-Based Best Practices for Outpatient Management of Warfarin. Ann Pharmacother 2018;52:1042-6. [PMID: 29890846 DOI: 10.1177/1060028018782473] [Reference Citation Analysis]
4 Rose AJ. Targeted approaches to improve outcomes for highest-cost patients. Isr J Health Policy Res 2017;6:25. [PMID: 28593037 DOI: 10.1186/s13584-017-0151-6] [Cited by in Crossref: 1] [Article Influence: 0.2] [Reference Citation Analysis]
5 McAlister FA, Wiebe N, Hemmelgarn BR. Time in therapeutic range and stability over time for warfarin users in clinical practice: a retrospective cohort study using linked routinely collected health data in Alberta, Canada.BMJ Open. 2018;8:e016980. [PMID: 29382672 DOI: 10.1136/bmjopen-2017-016980] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 3.0] [Reference Citation Analysis]
6 Phelps E, Delate T, Witt DM, Shaw PB, McCool KH, Clark NP. Effect of increased time in the therapeutic range on atrial fibrillation outcomes within a centralized anticoagulation service. Thromb Res 2018;163:54-9. [PMID: 29407629 DOI: 10.1016/j.thromres.2018.01.024] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
7 Rose AJ, Goldberg R, McManus DD, Kapoor A, Wang V, Liu W, Yu H. Anticoagulant Prescribing for Non-Valvular Atrial Fibrillation in the Veterans Health Administration. J Am Heart Assoc 2019;8:e012646. [PMID: 31441364 DOI: 10.1161/JAHA.119.012646] [Cited by in Crossref: 11] [Cited by in F6Publishing: 7] [Article Influence: 3.7] [Reference Citation Analysis]